Aquestive Therapeutics, Inc.: cashflow_financing
| Value | {"amount": 11592000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | Aquestive Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:35:24.527382+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/dd32d2e7-a4c3-41e5-bfde-9ccb6799088c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-24-009010Retrieved: 2026-08-19T13:35:24.527382+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001398733/cashflow-financing/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/dd32d2e7-a4c3-41e5-bfde-9ccb6799088c
History
- supersedes {"amount": 11562000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} (evidence 0001628280-23-010180)